טוען...
P-041. A case with chronic HBV infection who was non-responder to nucleos(t)ide analogues was treated with Pegylated interferon
INTRODUCTION: Pegylated interferon (Peg-IFN) and nucleos(t)ide analouges (NAs) are potential treatment options for chronic hepatitis B patients (CHB). Treatment response to NAs therapy is defined as an HBV DNA that cannot be detected by real-time polymerase chain reaction. Intermittent or persistent...
שמור ב:
| הוצא לאור ב: | Turk J Gastroenterol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Turkish Society of Gastroenterology
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7021053/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2019.47 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|